Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Trinity Biotech PLC changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 19 | −6 |
| SharesConverted for a 1-for-5 split | 1.20M | 6.04K | 2.92M | +1.72M (+144.0%) |
| Value | $2.58M | $13.0K | $5.95M | +$3.38M (+131.7%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Trinity Biotech PLC at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 1,800,000 | $3.67M | 0.06% |
| Moss Adams Wealth Advisors LLC | 25,666 | $52.4K | 0.01% |
| Susquehanna International Group, LLP | 13,572 | $27.8K | 0.00% |
| Global Retirement Partners, LLC | 800 | $1.63K | 0.00% |
| CIBC Private Wealth Group, LLC | 222 | $433 | 0.00% |
| Advisor Group Holdings, Inc. | 120 | $245 | 0.00% |
Sold out (12)
Institutions that held Trinity Biotech PLC at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 32,513 | $13.9K |
| Aristides Capital LLC | 28,057 | $12.0K |
| State of New Jersey Common Pension Fund D | 27,062 | $11.6K |
| CI Private Wealth, LLC | 22,035 | $9.45K |
| Two Sigma Securities, LLC | 19,037 | $8.17K |
| Millennium Management LLC | 15,466 | $6.63K |
| Redwood Wealth Management Group, LLC | 14,150 | $6.07K |
| Dynamic Advisor Solutions LLC | 10,000 | $5.30K |
| Williams & Novak, LLC | 10,000 | $4.29K |
| US Bancorp | 972 | $417 |
| Citigroup Inc | 4 | $2 |
| Simplex Trading, LLC | 488 | $0 |
Not filed for Q1 2024 yet (1)
Institutions that held Trinity Biotech PLC at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Wealthsource Partners, LLC | 30,200 | $13.0K |